The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD
- PMID: 22760170
- PMCID: PMC4154837
- DOI: 10.1097/WAD.0b013e318260a79a
The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD
Abstract
Hippocampal pathology occurs early in Alzheimer disease (AD), and atrophy, measured by volumes and volume changes, may predict which subjects will develop AD. Measures of the temporal horn (TH), which is situated adjacent to the hippocampus, may also indicate early changes in AD. Previous studies suggest that these metrics can predict conversion from amnestic mild cognitive impairment (MCI) to AD with conversion and volume change measured concurrently. However, the ability of these metrics to predict future conversion has not been investigated. We compared the abilities of hippocampal, TH, and global measures to predict future conversion from MCI to AD. TH, hippocampi, whole brain, and ventricles were measured using baseline and 12-month scans. Boundary shift integral was used to measure the rate of change. We investigated the prediction of conversion between 12 and 24 months in subjects classified as MCI from baseline to 12 months. All measures were predictive of future conversion. Local and global rates of change were similarly predictive of conversion. There was evidence that the TH expansion rate is more predictive than the hippocampal atrophy rate (P=0.023) and that the TH expansion rate is more predictive than the TH volume (P=0.036). Prodromal atrophy rates may be useful predictors of future conversion to sporadic AD from amnestic MCI.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.Neurology. 2008 Dec 9;71(24):1986-92. doi: 10.1212/01.wnl.0000336925.79704.9f. Neurology. 2008. PMID: 19064880 Free PMC article.
-
Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.Neurology. 2013 Feb 12;80(7):648-54. doi: 10.1212/WNL.0b013e318281ccd3. Epub 2013 Jan 9. Neurology. 2013. PMID: 23303849 Free PMC article.
-
Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.J Alzheimers Dis. 2015;48(1):197-204. doi: 10.3233/JAD-150063. J Alzheimers Dis. 2015. PMID: 26401940
-
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.Neurology. 2007 Mar 13;68(11):828-36. doi: 10.1212/01.wnl.0000256697.20968.d7. Neurology. 2007. PMID: 17353470
-
Neuroimaging of hippocampal atrophy in early recognition of Alzheimer's disease--a critical appraisal after two decades of research.Psychiatry Res Neuroimaging. 2016 Jan 30;247:71-8. doi: 10.1016/j.pscychresns.2015.08.014. Psychiatry Res Neuroimaging. 2016. PMID: 26774855 Review.
Cited by
-
Pathways of Prevention: A Scoping Review of Dietary and Exercise Interventions for Neurocognition.Brain Plast. 2019 Dec 26;5(1):3-38. doi: 10.3233/BPL-190083. Brain Plast. 2019. PMID: 31970058 Free PMC article.
-
Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors.Front Neurol. 2018 Aug 14;9:642. doi: 10.3389/fneur.2018.00642. eCollection 2018. Front Neurol. 2018. PMID: 30158893 Free PMC article.
-
Decreased Expression of Sulfatase 2 in the Brains of Alzheimer's Disease Patients: Implications for Regulation of Neuronal Cell Signaling.J Alzheimers Dis Rep. 2017;1(1):115-124. doi: 10.3233/ADR-170028. Epub 2017 Sep 28. J Alzheimers Dis Rep. 2017. PMID: 30035253 Free PMC article.
-
Multimodal Brain Imaging Reveals Structural Differences in Alzheimer's Disease Polygenic Risk Carriers: A Study in Healthy Young Adults.Biol Psychiatry. 2017 Jan 15;81(2):154-161. doi: 10.1016/j.biopsych.2016.02.033. Epub 2016 Mar 16. Biol Psychiatry. 2017. PMID: 27157680 Free PMC article.
-
Predictive Utility of Marketed Volumetric Software Tools in Subjects at Risk for Alzheimer Disease: Do Regions Outside the Hippocampus Matter?AJNR Am J Neuroradiol. 2017 Mar;38(3):546-552. doi: 10.3174/ajnr.A5061. Epub 2017 Jan 5. AJNR Am J Neuroradiol. 2017. PMID: 28057634 Free PMC article.
References
-
- Jellinger KA. Clinicopathological analysis of dementia disorders in the elderly—an update. J Alzheimers Dis. 2006;9:61–70. - PubMed
-
- Regeur L. Increasing loss of brain tissue with increasing dementia: a stereological study of post-mortem brains from elderly females. Eur J Neurol. 2000;7:47–54. - PubMed
-
- Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical